Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.AuthorsNarita, Yoshitaka; Nagane, Motoo; Mishima, Kazuhiko; Terui, Yasuhito; Arakawa, Yoshiki; Yonezawa, Hajime; Asai, Katsunori; Fukuhara, Noriko; Sugiyama, Kazuhiko; Shinojima, Naoki; Kitagawa, Junsaku; Aoi, Arata; Nishikawa, RyoPublicationNeuro-Oncology, 2021, Vol 23, Issue 1, p122ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/noaa145